GRAIL, Inc. (GRAL)

NASDAQ

$131.81

$+6.72

(+5.39%)

Regular Market

GRAIL, Inc. (GRAL) Live Price Chart

Last updated: ⁦2026-10-21 16:01:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

GRAIL, Inc. (GRAL) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $131.81, with a market capitalization of $5.47B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $41.50 to $166.48. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$5.47B
Open	$123.88
Day's High	$166.48
Day's Low	$12.33
Previous Close	$124.67
Volume	213.81K
Average Volume	999.17K
P/E Ratio	--
52-Week High	$166.48
52-Week Low	$41.50
Dividend Yield	--
Earnings Date	--

GRAIL, Inc. (GRAL) Stock Price Today

GRAIL, Inc. (GRAL) is currently trading at $131.81 as of 2026-10-21 15:59:00, up 5.73% ($7.14) from the previous close of $124.67

During today's regular trading session, GRAL has traded between $12.33 and $166.48, with a trading volume of 213.81K shares. The current price is near the upper end of today's range.

GRAIL, Inc. (GRAL) 7-Day Stock Price Change

Over the past seven days, GRAIL, Inc. (GRAL) moved from $137.37 to $131.81, representing a decline of 4.05% ($5.56).

The stock traded between $117.06 and $144.18 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 786.55 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

GRAL 52-Week Price Position

Position in Range: 72.3%

52W Low$41.50

52W High$166.48

GRAL is currently trading at $131.81, placing it 72.3% of the way from its 52-week low of $41.50 to its 52-week high of $166.48. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is GRAIL, Inc. (GRAL)?

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

GRAIL, Inc. Information

Industry	SERVICES-MEDICAL LABORATORIES
Employees	910
Exchange	NASDAQ
Company Website	https://www.grail.com

How to Buy GRAIL, Inc. (GRAL) Stock on MEXC

Eligible investors can buy real shares of GRAIL, Inc. (GRAL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GRAL and Place Your Order

Open the RealStocks trading page and search for GRAL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is GRAIL, Inc. (GRAL) stock price today?

GRAIL, Inc. (GRAL) is currently trading at $ 131.81, up 5.73% ($7.14) from the previous close of $ 124.67. Intraday prices update in real time during regular trading hours.

2.Is GRAL stock going up or down today?

As of 2026-10-21 15:59:00, GRAL is trading at $ 131.81, up 5.73% ($7.14) from its previous close of $ 124.67. The stock has traded between $ 12.33 and $ 166.48 during today’s regular session. Past price movements do not guarantee future results.

3.What is GRAL pre-market price?

As of 2026-10-21 15:59:00, GRAL is trading at $ 122.95 in pre-market trading, down 1.38% ($1.72) from the previous close of $ 124.67. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GRAL after-hours price?

As of 2026-10-21 15:59:00, GRAL is trading at $ 125.45 in after-hours trading, up 0.63% ($0.78) from the regular-session close of $ 124.67. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GRAL stock trading now?

GRAL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GRAL sit relative to its 52-week high and low?

Over the past 52 weeks, GRAL has traded between a low of $ 41.50 and a high of $ 166.48. At $ 131.81, the stock is positioned 72.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is GRAIL, Inc. in?

GRAIL, Inc. (GRAL) operates in the SERVICES-MEDICAL LABORATORIES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is GRAIL, Inc.'s market capitalization and where is it listed?

GRAIL, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 5.47B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GRAL valued in terms of P/E ratio and EPS?

GRAL trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -8.77. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does GRAIL, Inc. pay a dividend?

GRAIL, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.